<DOC>
	<DOCNO>NCT01669980</DOCNO>
	<brief_summary>This study safety effectiveness ceftaroline fosamil child Complicated Community-acquired Pneumonia receive antibiotic therapy hospital .</brief_summary>
	<brief_title>Safety Efficacy Study Ceftaroline Versus Comparator Pediatric Subjects With Complicated Community Acquired Pneumonia ( CABP )</brief_title>
	<detailed_description>To evaluate safety , effectiveness , pharmacokinetics tolerance ceftaroline fosamil pediatric subject age 2 month &lt; 18 year initially hospitalize Complicated Community Acquired Bacterial Pneumonia ( CABP ) high risk infection due methicillin-resistant Staphylococcus aureus ( MRSA )</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Presence CABP warrant 3 day initial hospitalization Confirmed presence indicator complicate CABP Hypersensitivity allergic reaction vancomycin Î²lactam antimicrobial Confirmed suspect infection pathogen know resistant IV study drug know infection baseline sole atypical organism Confirmed suspect respiratory tract infection attributable source community acquire bacterial pneumonia Noninfectious cause pulmonary infiltrates</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Infections</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Teflaro</keyword>
	<keyword>Ceftriaxone</keyword>
	<keyword>cephalosporin</keyword>
	<keyword>Vancomycin</keyword>
	<keyword>Clindamycin</keyword>
	<keyword>Amoxicillin Clavulanate</keyword>
	<keyword>Linezolid</keyword>
	<keyword>MRSA</keyword>
	<keyword>pneumonia</keyword>
</DOC>